Impact of Competition Law on Pharma Industry

In Depth

Impact of Competition Law on Pharma Industry

Payel Chatterjee, Simone Reis, Dr. Milind Antani | March 2013

This content is restricted to premium members only.

About Author

Payel Chatterjee

Payel Chatterjee, Member, International Litigation & Dispute Resolution and Competition Law Practice at Nishith Desai & Associates. Payel Chatterjee is an integral member of the International Litigation and Dispute Resolution Practice Group at the firm. She is also the winner of Best Paper (2012), awarded by Inter-Pacific Bar Association.

Simone Reis

Simone Reis, Co – Head, Competition Law Practice at Nishith Desai & Associates. Simone is a core member of the Mergers and Acquisitions and the Competition Law practice at the firm. Simone’s practice focuses on mergers and acquisitions, private equity and venture capital investments, domestic and international.

Dr. Milind Antani

Dr. Milind Antani is Partner in charge of Pharma-Life Sciences and Healthcare Practice at Nishith Desai Associates. Dr. Antani represents clients in matters including corporate mergers and acquisitions, investments, regulatory and transactional matters, intellectual property prosecution and litigation, joint ventures and formation of new companies.